- Trials with a EudraCT protocol (624)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
624 result(s) found for: Sputum.
Displaying page 1 of 32.
EudraCT Number: 2020-004377-44 | Sponsor Protocol Number: Ambroxpall | Start Date*: 2021-08-24 |
Sponsor Name:Med. Univ. Wien, Innere Med. I, Abt. f. Palliativmedizin | ||
Full Title: Ambroxol inhalation for mucus clearance in palliative care patients - a randomized placebo-controlled double-blind pilot study. | ||
Medical condition: cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000244-26 | Sponsor Protocol Number: PC-ASP-004 | Start Date*: 2018-08-21 | ||||||||||||||||
Sponsor Name:Pulmocide Ltd | ||||||||||||||||||
Full Title: A double-blind, placebo-controlled study to assess the effects of inhaled PC945 in the treatment of culture-positive Aspergillus or Candida fungal bronchitis in subjects with moderate to severe ast... | ||||||||||||||||||
Medical condition: Pulmonary aspergillosis and candidiasis of lung | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-002014-52 | Sponsor Protocol Number: FOOTSTEP | Start Date*: 2019-01-23 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: DUAL HOMING MECHANISMS OF EOSINOPHILS TO THE SPUTUM; ONLY ONE OF WHICH IS SENSITIVE FOR MEPOLIZUMAB | ||
Medical condition: severe eosinophilic asthma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-001412-30 | Sponsor Protocol Number: HMR3647A/4020 | Start Date*: 2005-12-02 |
Sponsor Name:Laboratoire Aventis | ||
Full Title: An open-label, randomized, multicenter, clinical study to compare the effects of telithromycin, azithromycin and cefuroxime axetil on the penicillin or macrolide resistance of Streptococcus pneumon... | ||
Medical condition: Patients with acute exacerbation of chronic bronchitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-004389-17 | Sponsor Protocol Number: TR02-103 | Start Date*: 2005-12-28 |
Sponsor Name:Transave, Inc | ||
Full Title: SAFETY AND TOLERABILITY STUDY OF SLIT AMIKACIN 500 MG ONCE DAILY FOR 14 DAYS BY INHALATION IN CYSTIC FIBROSIS STUDY SUBJECTS CHRONICALLY INFECTED WITH PSEUDOMONAS AERUGINOSA | ||
Medical condition: Cystic Fibrosis with mild to moderate obstructive lung disease and chronic infection with Pseudomonas aeruginosa | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-000753-35 | Sponsor Protocol Number: D0520C00010 | Start Date*: 2009-02-20 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Phase II, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy of 28 Day Oral Administration of AZD9668 in Patients with Bronchiectasis | |||||||||||||
Medical condition: Bronchiectasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003374-14 | Sponsor Protocol Number: SAV008-01 | Start Date*: 2018-04-06 | |||||||||||
Sponsor Name:Savara ApS | |||||||||||||
Full Title: An Open-label, non-controlled, multicenter, Pilot clinical Trial of Inhaled Molgramostim in subjects with Antibiotic-resistant non-tuberculosis mycobacterial (NTM) infection | |||||||||||||
Medical condition: Treatment-resistant pulmonary non-tuberculosis mycobacterial (NTM) infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-000243-87 | Sponsor Protocol Number: PC_ASP_003 | Start Date*: 2018-11-19 | |||||||||||
Sponsor Name:Pulmocide Ltd | |||||||||||||
Full Title: An open-label study to assess the safety, pharmacokinetics and pharmacodynamics of inhaled PC945 in adult Cystic Fibrosis (CF) patients with persistent pulmonary Aspergillus fumigatus infection. | |||||||||||||
Medical condition: Pulmonary aspergillosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004381-33 | Sponsor Protocol Number: CQAW039A2127 | Start Date*: 2019-12-11 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: Randomized, subject and investigator blinded, placebo-controlled study to demonstrate the anti-inflammatory effect of fevipiprant (QAW039) in moderate-severe asthma patients with high sputum and... | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) FR (Prematurely Ended) DE (Prematurely Ended) ES (Prematurely Ended) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023828-24 | Sponsor Protocol Number: 09107 | Start Date*: 2011-06-09 |
Sponsor Name:University of Nottingham | ||
Full Title: The effect of Thalidomide on sputum biomarkers in IPF cough. | ||
Medical condition: Cough in Idiopathic Pulmonary fibrosis. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-002584-90 | Sponsor Protocol Number: D1511C00002 | Start Date*: 2005-08-22 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A Randomised, Double-Blind, Placebo-Controlled, Two-Way Crossover Study in Healthy Volunteers to Investigate the Effect of Oral Dosing with AZD8309 on Airway Inflammation as Assessed in Induced Spu... | ||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-002202-31 | Sponsor Protocol Number: POL7080-002 | Start Date*: 2013-09-11 |
Sponsor Name:Polyphor Ltd. | ||
Full Title: A phase II, open-label, multi-center study to assess the tolerance, safety, efficacy and pharmacokinetics/pharmacodynamics (PK/PD) of POL7080 in the treatment of patients with acute exacerbation of... | ||
Medical condition: Acute exacerbation of non-cystic fibrosis bronchiectasis due to Pseudomonas aeruginosa infection. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) ES (Prematurely Ended) DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-000264-17 | Sponsor Protocol Number: ARD-3100-0703 | Start Date*: 2008-08-19 | |||||||||||
Sponsor Name:Aradigm Corporation | |||||||||||||
Full Title: A MULTI-CENTER, OPEN-LABEL, PROOF-OF-CONCEPT STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFECT ON SPUTUM PSEUDOMONAS AERUGINOSA DENSITY OF INHALED LIPOSOMAL CIPROFLOXACIN HYDROCHLORIDE IN ADUL... | |||||||||||||
Medical condition: To evaluate the safety, tolerability, and effect on sputum P. aeruginosa density of two dose levels of liposomal ciprofloxacin hydrochloride for inhalation in adult subjects with non-CF bronchiecta... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002938-20 | Sponsor Protocol Number: 13031 | Start Date*: 2013-11-08 |
Sponsor Name:University of Nottingham | ||
Full Title: An open label trial of azithromycin in chronic productive cough | ||
Medical condition: The medical condition that will be investigated is that of chronic productive cough (with or without a diagnosis of asthma but without a diagnosis of bronchiectasis, smoking related chronic bronchi... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-001626-22 | Sponsor Protocol Number: RML-TB | Start Date*: 2022-03-28 |
Sponsor Name:Vall d'Hebron Institute of Research | ||
Full Title: A Multicentre Controlled Open Randomized Clinical Trial to evaluate the efficacy and safety profile of an anti-TB drug combination based on High Dose Rifampicin, High Dose Moxifloxacin and Linezoli... | ||
Medical condition: Smear-positive rifampicin-sensitive pulmonary Tuberculosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-006276-11 | Sponsor Protocol Number: VR496/005 | Start Date*: 2008-09-01 | |||||||||||
Sponsor Name:Vectura Limited | |||||||||||||
Full Title: A Phase I/II randomised, placebo-controlled, double blind trial to assess the safety, tolerability, pharmacodynamics and exploratory efficacy of heparin 25 mg inhalation powder in patients with Cys... | |||||||||||||
Medical condition: Cystic Fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) IE (Completed) PL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002854-39 | Sponsor Protocol Number: CAIN457A2104 | Start Date*: 2009-01-15 |
Sponsor Name:Novartis Pharma Services AG | ||
Full Title: A double blind, placebo controlled, parallel group study with an open label reference arm to assess the effects of intravenously administered AIN457 on ozone induced neutrophilia compared to placeb... | ||
Medical condition: Healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005452-41 | Sponsor Protocol Number: DPM-B-301 | Start Date*: 2006-05-26 |
Sponsor Name:Pharmaxis UK Limited | ||
Full Title: A phase III Multicenter, randomised, parallel, placebo-controlled, double-blind study to investigate the safety and efficacy of treatment with Bronchitol (dry powder mannitol) in the symptomatic tr... | ||
Medical condition: Bronchiectasis | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-004966-13 | Sponsor Protocol Number: CQAW039A2208 | Start Date*: 2011-12-20 | ||||||||||||||||
Sponsor Name:Novartis Pharma Services AG | ||||||||||||||||||
Full Title: A double-blind, placebo-controlled, study examining the effect of orally administered QAW039 on sputum eosinophil levels and other efficacy outcomes in patients with sputum eosinophilia and pers... | ||||||||||||||||||
Medical condition: sputum eosinophilia and moderate-to-severe asthma (GINA 2-5) incompletely controlled on current therapy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-000398-19 | Sponsor Protocol Number: AGO/2016/002 | Start Date*: 2016-03-08 |
Sponsor Name:Ghent University | ||
Full Title: Pilot study: pharmacokinetics of beta-lactam antibiotics, piperacillin-tazobactam, ceftazidim and meropenem in blood and sputum of cystic fibrosis patients. | ||
Medical condition: Cystic fibrosis | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: BE (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
